Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Alexandre de Araujo is active.

Publication


Featured researches published by Alexandre de Araujo.


Hepatology Research | 2014

Oral l-ornithine-l-aspartate in minimal hepatic encephalopathy: A randomized, double-blind, placebo-controlled trial.

Mário Reis Álvares-da-Silva; Alexandre de Araujo; João Reinhardt Vicenzi; Gabriel Veber Moisés da Silva; Fabiana Bazanella de Oliveira; Fernando Comunello Schacher; Lucas Santos Oliboni; Aline Marino Magnus; Letícia Rosito Pinto Kruel; Rita Gigliola Gomes Prieb; Luiz Nelson Teixeira Fernandes

Evaluate efficacy/safety of oral l‐ornithine‐l‐aspartate (LOLA) in controlling minimal hepatic encephalopathy (MHE).


Gut | 2012

Low-dose albumin in the treatment of spontaneous bacterial peritonitis: should we change the standard treatment?

Alexandre de Araujo; Antonio de Barros Lopes; Gabriela Rossi; Gabriel Veber Moisés da Silva; Patrícia Ananias; Sandro Ness; Mário Reis Álvares-da-Silva

We read with interest the recent paper published on the management of patients awaiting liver transplant.1 The authors carried out a comprehensive review of liver complications, including spontaneous bacterial peritonitis (SBP). They stated that intravenous albumin (IV-A) at a dose of 1.5 g/kg at diagnosis and 1 g/kg 48 h later has been shown to prevent renal impairment and reduces mortality. We would like to address this point as this benefit has only been demonstrated in one clinical trial in which an arbitrary dose of albumin was used.2 …


Annals of Hepatology | 2017

Treatment of Chronic HCV Infection with the New Direct Acting Antivirals (DAA): First Report of a Real World Experience in Southern Brazil

Hugo Cheinquer; Hoel Sette-Jr; Fernando Herz Wolff; Alexandre de Araujo; Silvia Coelho-Borges; Silvia R.P. Soares; Mauricio F.A. Barros

INTRODUCTION AND AIM There is almost no data regarding the efficacy of direct acting antivirals (DAAs) therapy in Brazil. The aim of this historical cohort study is to describe the sustained virologic response (SVR) rate among real-world compensated chronic hepatitis C patients in three hepatology centers from Southern Brazil. MATERIALS AND METHODS Patients were included if they had at least 12 weeks follow-up after the end of therapy. Patients that were lost to follow-up or had treatment prematurely interrupted for any reason were considered treatment failure in this intention to treat analysis. RESULTS 219 patients were analyzed. Mean age was 57.4 ± 10.9 years and 142/219 (64.8%) were male. Genotype 1 was present in 166 patients (75.8%; 1a 29.2%, 1b 46.6%); Genotypes 2, 3 and 4 in 8 (3.7%), 43 (19.6%) and 2 (0.9%), respectively. 96 (43.8%) were cirrhotic. 134 (59.5%) were treatment experienced. DAA therapies were: sofosbuvir (SOF) + ribavirin (RBV) in 10 patients; SOF + simeprevir (SMV) ± RBV in 73; SOF + pegylated interferon (PEG-IFN) + RBV in 6; SOF + daclatasvir (DCV) ± RBV in 51, SOF + ledipasvir (LDV) ± RBV in 61, and par-itaprevir/ritonavir + ombitasvir + dasabuvir (PTVr/OBV/DSV) ± RBV in 18 patients. SVR-12 was achieved in 208/219 (95%). Ten patients had virologic failure: 6 cirrhotic, 7 treatment experienced, and 6 either genotype 3 or 1a. No adverse event was attributed to the DAA therapy. CONCLUSIONS Real world experience with DAA therapy in Southern Brazil showed a high rate of SVR and excellent tolerability. Failure to achieve SVR was mainly observed among patients with at least one negative predictor of response: cirrhosis and/or genotypes 1a or 3.INTRODUCTION AND AIM There is almost no data regarding the efficacy of direct acting antivirals (DAAs) therapy in Brazil. The aim of this historical cohort study is to describe the sustained virologic response (SVR) rate among real-world compensated chronic hepatitis C patients in three hepatology centers from Southern Brazil. MATERIALS AND METHODS Patients were included if they had at least 12 weeks follow-up after the end of therapy. Patients that were lost to follow-up or had treatment prematurely interrupted for any reason were considered treatment failure in this intention to treat analysis. RESULTS 219 patients were analyzed. Mean age was 57.4 ± 10.9 years and 142/219 (64.8%) were male. Genotype 1 was present in 166 patients (75.8%; 1a 29.2%, 1b 46.6%); Genotypes 2, 3 and 4 in 8 (3.7%), 43 (19.6%) and 2 (0.9%), respectively. 96 (43.8%) were cirrhotic. 134 (59.5%) were treatment experienced. DAA therapies were: sofosbuvir (SOF) + ribavirin (RBV) in 10 patients; SOF + simeprevir (SMV) ± RBV in 73; SOF + pegylated interferon (PEG-IFN) + RBV in 6; SOF + daclatasvir (DCV) ± RBV in 51, SOF + ledipasvir (LDV) ± RBV in 61, and paritaprevir/ ritonavir + ombitasvir + dasabuvir (PTVr/OBV/DSV) ± RBV in 18 patients. SVR-12 was achieved in 208/219 (95%). Ten patients had virologic failure: 6 cirrhotic, 7 treatment experienced, and 6 either genotype 3 or 1a. No adverse event was attributed to the DAA therapy. CONCLUSIONS Real world experience with DAA therapy in Southern Brazil showed a high rate of SVR and excellent tolerability. Failure to achieve SVR was mainly observed among patients with at least one negative predictor of response: cirrhosis and/or genotypes 1a or 3.


Gastroenterology Research and Practice | 2016

Transarterial Embolization and Percutaneous Ethanol Injection as an Effective Bridge Therapy before Liver Transplantation for Hepatitis C-Related Hepatocellular Carcinoma

Marcio F. Chedid; Leandro Armani Scaffaro; Aljamir Duarte Chedid; Antonio Carlos Maciel; Carlos Thadeu Schmidt Cerski; M. Reis; Tomaz Maria de Jesus Grezzana-Filho; Alexandre de Araujo; Ian Leipnitz; Cleber Dario Pinto Kruel; Mário Reis Álvares-da-Silva; Cleber Rosito Pinto Kruel

Background. Transarterial chemoembolization alone or in association with radiofrequency ablation is an effective bridging strategy for patients with hepatocellular carcinoma awaiting for a liver transplant. However, cost of this therapy may limit its utilization. This study was designed to evaluate the outcomes of a protocol involving transarterial embolization, percutaneous ethanol injection, or both methods for bridging hepatocellular carcinomas prior to liver transplantation. Methods. Retrospective review of all consecutive adult patients who underwent a first liver transplant as a treatment to hepatitis C-related hepatocellular carcinoma at our institution between 2002 and 2012. Primary endpoint was patient survival. Secondary endpoint was complete tumor necrosis. Results. Forty patients were analyzed, age 58 ± 7 years. There were 23 males (57.5%). Thirty-six (90%) out of the total 40 patients were within Milan criteria. Complete necrosis was achieved in 19 patients (47.5%). One-, 3-, and 5-year patient survival were, respectively, 87.5%, 75%, and 69.4%. Univariate analysis did not reveal any variable to impact on overall patient survival. Conclusions. Transarterial embolization, ethanol injection, or the association of both methods followed by liver transplantation comprises effective treatment strategy for hepatitis C-related hepatocellular carcinoma. This strategy should be adopted whenever transarterial chemoembolization and/or radiofrequency ablation are not available options.


Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery | 2016

ESTIMATING BASAL ENERGY EXPENDITURE IN LIVER TRANSPLANT RECIPIENTS: THE VALUE OF THE HARRIS-BENEDICT EQUATION

Andressa dos Santos Pinto; Marcio F. Chedid; Léa Teresinha Guerra; Mário Reis Álvares-da-Silva; Alexandre de Araujo; Luciano Santos Pinto Guimarães; Ian Leipnitz; Aljamir Duarte Chedid; Cleber Rosito Pinto Kruel; T.J.M. Grezzana-Filho; Cleber Dario Pinto Kruel

ABSTRACT Background: Reliable measurement of basal energy expenditure (BEE) in liver transplant (LT) recipients is necessary for adapting energy requirements, improving nutritional status and preventing weight gain. Indirect calorimetry (IC) is the gold standard for measuring BEE. However, BEE may be estimated through alternative methods, including electrical bioimpedance (BI), Harris-Benedict Equation (HBE), and Mifflin-St. Jeor Equation (MSJ) that carry easier applicability and lower cost. Aim: To determine which of the three alternative methods for BEE estimation (HBE, BI and MSJ) would provide most reliable BEE estimation in LT recipients. Methods: Prospective cross-sectional study including dyslipidemic LT recipients in follow-up at a 735-bed tertiary referral university hospital. Comparisons of BEE measured through IC to BEE estimated through each of the three alternative methods (HBE, BI and MSJ) were performed using Bland-Altman method and Wilcoxon Rank Sum test. Results: Forty-five patients were included, aged 58±10 years. BEE measured using IC was 1664±319 kcal for males, and 1409±221 kcal for females. Average difference between BEE measured by IC (1534±300 kcal) and BI (1584±377 kcal) was +50 kcal (p=0.0384). Average difference between the BEE measured using IC (1534±300 kcal) and MSJ (1479.6±375 kcal) was -55 kcal (p=0.16). Average difference between BEE values measured by IC (1534±300 kcal) and HBE (1521±283 kcal) was -13 kcal (p=0.326). Difference between BEE estimated through IC and HBE was less than 100 kcal for 39 of all 43patients. Conclusions: Among the three alternative methods, HBE was the most reliable for estimating BEE in LT recipients.


Journal of Gastroenterology and Hepatology | 2008

Is there yet any place for reagent strips in diagnosing spontaneous bacterial peritonitis in cirrhotic patients? An accuracy and cost-effectiveness study in Brazil

Alexandre de Araujo; Antonio de Barros Lopes; Matheus Trucollo Michalczuk; Jonathas Stifft; Enzo Nardelli; Gabriela Fortes Escobar; Gabriela Rossi; Mário Reis Álvares-da-Silva

Background:  Diagnosis of spontaneous bacterial peritonitis (SBP) is currently based on ascitic cell counting, but there is a need for a more simple and rapid diagnostic tool. The objectives of this study are to evaluate the accuracy of reagent strips in diagnosing SBP and compare their costs with total and differential cell counts.


Hepatology | 2007

Lower cutoff values for dipsticks may improve their accuracy in rapid diagnosis of spontanous bacterial peritonitis

Antonio de Barros Lopes; Alexandre de Araujo; Mario Reis Alvares-da Silva

1996;24(Suppl):445A.5. Jeffries MA, Stern MA, Gunaratnam NT, Fontana RS. Unsuspected in-fection is infrequent in asymptomatic outpatients with refractory ascitesundergoing therapeutic paracentesis. Am J Gastroenterol 1999;94:2972-2976.6. RomneyR,MathurinP,Ganne-Carrie´ N,HalimiCH,MediniA,LematreP, et al. Usefulness of routine analysis of ascitic fluid at the time of thera-peutic paracentesis in asymptomatic outpatients. Gastroenterol Clin Biol2005;29:275-279.7. Castellote J, Girbau A, Maisterra S, Charhi N, Ballester R, Xiol X. Spon-taneous bacterial peritonitis and bacterascites prevalence in asymptomaticcirrhotic outpatients undergoing large-volume paracentesis. J Gastroen-terol Hepatol, in press.


RENOTE | 2013

A CONSTRUÇÃO DO BLOG COMO PORTFÓLIO DE APRENDIZAGEM

Mariangela Kraemer Lenz Ziede; Simone Bicca Charczuk; Alexandre de Araujo; Rosane Aragón

Este artigo tem como objetivo o estudo do processo de construcao da compreensao do Blog como Portfolio de Aprendizagem, por meio da analise desta ferramenta, realizada pelos proprios sujeitos. A analise dos alunos acerca do uso dos blogs foi realizada a partir do conceito de abstracao reflexionante proposto por Piaget. A coleta de dados ocorreu a partir do levantamento dos registros de 15 blogs de um grupo de alunos de um dos cinco polos do Curso de Pedagogia Licenciatura na modalidade a distância da Universidade Federal do Rio Grande do Sul. Os dados foram organizados com o apoio do software de pesquisa Nvivo e analisados a partir da teoria. Foram propostos niveis elencados em quatro categorias: i) Compreensao empirica; ii) Compreensao Pseudo-empirica; iii) Compreensao refletida; iv) Compreensao Meta- refletida. Concluimos que no decorrer do curso os alunos elaboraram postagens que puderam ser compreendidas nos diversos niveis de abstracao, conforme categorias mencionadas. Se no inicio do curso o blog era entendido apenas com um espaco para escrever, a ideia de portfolio foi construida nas interacoes oportunizadas pelo acompanhamento dos tutores e professores e pela rede de aprendizagem na qual ocorriam trocas constantes entre os alunos.


Langenbeck's Archives of Surgery | 2015

Low serum factor V level: early predictor of allograft failure and death following liver transplantation

Mauricio C. Zulian; Marcio F. Chedid; Aljamir Duarte Chedid; Tomáz de Jesus Maria Grezzana Filho; Ian Leipnitz; Alexandre de Araujo; Mário Reis Álvares-da-Silva; Mario G. Cardoni; Luciano Santos Pinto Guimarães; Cleber Dario Pinto Kruel; Cleber Rosito Pinto Kruel


Annals of Hepatology | 2014

Akin criteria as a predictor of mortality in cirrhotic patients after spontaneous bacterial peritonitis.

Alexandre de Araujo; Mário Reis Álvares-da-Silva

Collaboration


Dive into the Alexandre de Araujo's collaboration.

Top Co-Authors

Avatar

Mário Reis Álvares-da-Silva

Universidade Federal do Rio Grande do Sul

View shared research outputs
Top Co-Authors

Avatar

Aljamir Duarte Chedid

Universidade Federal do Rio Grande do Sul

View shared research outputs
Top Co-Authors

Avatar

Ian Leipnitz

Universidade Federal do Rio Grande do Sul

View shared research outputs
Top Co-Authors

Avatar

Antonio de Barros Lopes

Universidade Federal do Rio Grande do Sul

View shared research outputs
Top Co-Authors

Avatar

Cleber Rosito Pinto Kruel

Universidade Federal do Rio Grande do Sul

View shared research outputs
Top Co-Authors

Avatar

Cleber Dario Pinto Kruel

Universidade Federal do Rio Grande do Sul

View shared research outputs
Top Co-Authors

Avatar

Gabriel Veber Moisés da Silva

Universidade Federal do Rio Grande do Sul

View shared research outputs
Top Co-Authors

Avatar

Gabriela Rossi

Universidade Federal do Rio Grande do Sul

View shared research outputs
Top Co-Authors

Avatar

Aline Marino Magnus

Universidade Federal do Rio Grande do Sul

View shared research outputs
Top Co-Authors

Avatar

Fernando Comunello Schacher

Universidade Federal do Rio Grande do Sul

View shared research outputs
Researchain Logo
Decentralizing Knowledge